Get the app
USHealthcare

Stryker Corporation (SYK)

US · Healthcare · Medical Devices

$280.34-1.55%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$6.59B
Revenue YoY
+9.4%
Net profit
$1.28B
Profit YoY
+44.3%
EPS
$3.69
EPS estimate
$3.46
Net margin
19.4%

EPS came in at 3.69 against a street estimate of 3.46 — a beat of 6.6%.

Key statistics

Market cap
$105.70B
P/E
28.6
Forward P/E
16.5
P/B
4.41
Book value
$62.54
EPS (TTM)
$9.64
Dividend yield
1.29%
52-week high
$389.48
52-week low
$267.00
50-day MA
$325.03
200-day MA
$336.68
Beta
0.77

Analyst view

Analysts rate Stryker Corporation a buy (22 buy, 9 hold, 1 sell out of 32) with an average price target of $376.28.

From the latest earnings call · 2026-07-30

CONFIDENT Stryker delivered 9% organic growth in Q2 recovering from cyber incident. Beat EPS estimates with strong capital equipment demand and elevated backlog. Narrowed full-year guidance, expecting robust H2 driven by production ramp and new product launches. Q2 2026 U.S. and international both healthy; international shows broad geographic strength despite localized geopolitical friction. Analysts pressed on H2 growth mechanics (catch-up vs. underlying, production constraints, margin cadence), peripheral vascular recovery risk, and EPS guide conservatism vs. Q2 beat. Management emphasized order visibility, manufacturing capacity added via shifts, and execution track record—but acknowledged cyber headwinds and tariff timing volatility persist. 2026-07-30…

Full summary in the app.

Shareholding

Insiders
5.36%
Institutions
82.85%

Largest institutional holders

FundStake
BlackRock Inc7.20%
Vanguard Capital Management, LLC5.84%
JPMorgan Chase & Co4.07%
State Street Corp4.00%
Greenleaf Trust3.97%
T. Rowe Price Associates, Inc.2.62%
Vanguard Portfolio Management, LLC2.17%
Wellington Management Company LLP2.13%

Recent filings & reports

DocumentDate
Quarterly report · Q2 2026
STRYKER CORPORATION - FORM 10-Q SUMMARY For Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Net sales (6 months 2026): $12,609 million vs. $11,8
2026-07-31
Results announced · Q3 2026
STRYKER CORPORATION Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net sales: $6.6 billion, up 9.4% reported, 9.0% organic • Reported EPS: $3.30, up 44
2026-07-30
Company announcement · Q2 2026
STRYKER CORPORATION FORM 8-K SUMMARY (JUNE 26, 2026) BUSINESS & SEGMENT HIGHLIGHTS • Stryker announced organizational restructuring in Q1 2026, crea
2026-06-26
Board / officer change · Q2 2026
STRYKER CORPORATION (SYK) – 8-K FILING SUMMARY HEADLINE NUMBERS • Leadership transition effective September 1, 2026: William E. Berry Jr. retiring a
2026-05-20
Quarterly report · Q1 2026
STRYKER CORPORATION – Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Net sales: $6,020 million (Q1 2026) vs $5,866 million (Q1 2025) – up 2.6% • Net e
2026-05-11
Shareholder vote results · Q2 2026
STRYKER CORPORATION (SYK) - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Shareholder Meeting held May 6, 2026 • Total voting shares cast: approximatel
2026-05-08
Proxy statement · Q2 2026
STRYKER CORPORATION PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION & CHANGE Kevin A. Lobo (Chair and CEO): - 2025 Total Compensation: $20,835,000 -
2026-03-23
Annual report FY2025
STRYKER CORPORATION – 2025 FORM 10-K SUMMARY HEADLINE NUMBERS • Total Net Sales 2025: $25,116 million, up from $22,595 million in 2024 (11.2% increa
2026-02-11

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.88 / share
ex-date Sep 30, 2026 · pay Oct 30, 2026
2026-09-30
Dividend$0.88 / share
ex-date Jun 30, 2026 · pay Jul 31, 2026
2026-06-30
Dividend$0.88 / share
ex-date Mar 31, 2026 · pay Apr 30, 2026
2026-03-31
Dividend$0.88 / share
ex-date Dec 31, 2025 · pay Jan 30, 2026
2025-12-31
Dividend$0.84 / share
ex-date Sep 30, 2025 · pay Oct 31, 2025
2025-09-30

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Stryker Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.